论文部分内容阅读
目的:观察川芎嗪联合酚妥拉明对老年慢性肺源性心脏病的临床疗效。方法:选择2014年1月至2015年12月本院就诊的100例老年慢性肺源性心脏病患者,随机分为两组,对照组患者实施常规治疗,观察组在对照组基础上加用川芎嗪联合酚妥拉明,统计分析与比较两组患者的临床治疗效果。结果:观察组患者的临床治疗有效率为96%显著优于对照组的80%(P<0.05)。观察组患者的并发症发生率为22%显著低于对照组的72%(P<0.05)。结论:川芎嗪联合酚妥拉明对老年慢性肺源性心脏病临床疗效满意。
Objective: To observe the clinical effect of ligustrazine and phentolamine on senile chronic pulmonary heart disease. Methods: A total of 100 elderly patients with chronic cor pulmonale who visited our hospital from January 2014 to December 2015 were randomly divided into two groups. Patients in the control group received routine treatment. The observation group was treated with Chuanxiong Triazine combined with phentolamine, statistical analysis and comparison of clinical treatment of two groups of patients. Results: The effective rate of clinical treatment in observation group was significantly higher than that in control group (96%) (P <0.05). The incidence of complications in the observation group was significantly lower than 22% in the control group (22%) (P <0.05). Conclusion: Ligustrazine combined with phentolamine is effective in elderly patients with chronic cor pulmonale.